Sjögren-Larsson syndrome. Impaired fatty alcohol oxidation in cultured fibroblasts due to deficient fatty alcohol:nicotinamide adenine dinucleotide oxidoreductase activity.
about
Pathobiology of the stratum corneum.Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher diseaseIsolation and characterization of a Chinese hamster ovary cell line deficient in fatty alcohol:NAD+ oxidoreductase activityThe molecular basis of Sjögren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene.Sjögren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol:NAD+ oxidoreductase in cultured fibroblasts.Novel and recurrent ALDH3A2 mutations in Italian patients with Sjögren-Larsson syndrome.Abnormal fatty alcohol metabolism in cultured keratinocytes from patients with Sjögren-Larsson syndrome.The role of fatty aldehyde dehydrogenase in epidermal structure and function.Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors.Large contiguous gene deletions in Sjögren-Larsson syndromeGenetic homogeneity in Sjögren-Larsson syndrome: linkage to chromosome 17p in families of different non-Swedish ethnic originsSjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.Genetics and prospective therapeutic targets for Sjögren-Larsson Syndrome.Fatty aldehyde and fatty alcohol metabolism: review and importance for epidermal structure and function.Sjögren-Larsson syndrome in clinical practice.Isolation of animal cell mutants defective in long-chain fatty aldehyde dehydrogenase. Sensitivity to fatty aldehydes and Schiff's base modification of phospholipids: implications for Sj-ogren-Larsson syndrome.Studying fatty aldehyde metabolism in living cells with pyrene-labeled compounds.Inhibition of rat lipoprotein lipid peroxidation by the oral administration of D003, a mixture of very long-chain saturated fatty acids.Evidence for two enzymatic pathways for omega-oxidation of docosanoic acid in rat liver microsomes.Involvement of microsomal fatty aldehyde dehydrogenase in the alpha-oxidation of phytanic acid.Report of a Turkish child with Sjören-Larsson syndrome associated with peripheral nerve involvement.Cholesterol-lowering effect of policosanol on rabbits with hypercholesterolaemia induced by a wheat starch-casein diet.Disorders of Keratinization
P2860
Q24539142-4E149C49-FCDD-4080-BFCF-C80CE240AB4CQ28369639-1A4E6118-4D9F-43A1-9512-ABA51018D85EQ33737425-B025EAF2-542C-45F1-B818-BC37C463DA92Q34146285-D7E1E7DD-C19F-4D02-AF02-E96CBAA517A6Q34209686-A455390B-BFA2-4D4F-81A6-5BDA92566EDBQ34671153-5A7B6896-6BEA-47C7-ABC0-73B33B9B46BFQ34671265-2978BF91-C781-4F9F-AC6B-C18091CB977DQ35050721-54F4B9EA-88E5-4740-A9D6-E1911652D4AFQ35130660-E8C7D7C3-8A59-440E-BCFC-C951F7741AE9Q35387343-3DA3536A-6F99-45B5-9089-CBEABBE69221Q35644016-F7F9EFCA-6D0B-40FC-942E-4D4ACD9B10D3Q35914755-68EA409F-3C3C-4C24-BE6C-28F073A3725AQ37185656-598635D0-C3BE-45C8-958F-4318D0049DDAQ37714304-4A54E212-BA58-44E0-ADEC-07E6237D1683Q38029551-36B2FC60-2AE5-42A4-860A-A6EB6009A22DQ41091130-29AAAF8C-AEF0-4AD6-B43B-583FF7D1B15EQ42191988-7A1FD5A9-A4DE-4770-90A5-30AB198C2B97Q43929860-681A55A8-9B45-4390-B08D-A6EA7A763B6EQ45270091-33A877E0-16FF-415C-91F5-F242A5B17778Q47852289-4C3A869E-D447-4B54-904F-83B6946956A5Q51949313-4A81F48D-9911-4EA3-867F-1D9E29487FA4Q53733418-2480259C-46D9-40B5-BA59-AA04CB53D3E1Q58859701-F9EFCEAB-D8D9-4A12-8A2A-F18ED7377F2A
P2860
Sjögren-Larsson syndrome. Impaired fatty alcohol oxidation in cultured fibroblasts due to deficient fatty alcohol:nicotinamide adenine dinucleotide oxidoreductase activity.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Sjögren-Larsson syndrome. Impa ...... otide oxidoreductase activity.
@ast
Sjögren-Larsson syndrome. Impa ...... otide oxidoreductase activity.
@en
type
label
Sjögren-Larsson syndrome. Impa ...... otide oxidoreductase activity.
@ast
Sjögren-Larsson syndrome. Impa ...... otide oxidoreductase activity.
@en
prefLabel
Sjögren-Larsson syndrome. Impa ...... otide oxidoreductase activity.
@ast
Sjögren-Larsson syndrome. Impa ...... otide oxidoreductase activity.
@en
P2093
P2860
P356
P1476
Sjögren-Larsson syndrome. Impa ...... otide oxidoreductase activity.
@en
P2093
P2860
P304
P356
10.1172/JCI113379
P407
P577
1988-03-01T00:00:00Z